Literature DB >> 7641971

Relaxant effects of nitric oxide and cyclic GMP on pregnant rat uterine longitudinal smooth muscle.

H Izumi1, R E Garfield.   

Abstract

The purpose of our study was to examine the relaxant effects of sodium nitroprusside (SNP) and cyclic guanosine 3'-5'-monophosphate (cGMP) on pregnant rat myometrium. Using very thin muscle strips, which allows diffusional access of applied drugs (in a few seconds), contractile properties were examined. This technique facilitates study of SNP's effects on uterine contractility as nitric oxide is rapidly inactivated to NO2. SNP did not decrease the amplitudes of 45 mmol/l KCl contractions but decreased spontaneous contractions and 1 mumol/l carbachol contractions. The relaxation of carbachol contractions by SNP were antagonized by methylene blue. In addition, 8-bromo-cyclic guanosine monophosphate (8-bromo-cGMP) also inhibited KCl-, carbachol- and oxytocin-induced contractions, however, the relaxant effect of 8-bromo-cGMP was much greater on carbachol and oxytocin contractions than on KCl contractions. Cyclic GMP (1 microM) decreased contractions evoked by various concentrations of Ca2+ and carbachol with 1 mumol/l GTP-gamma S in skinned (membrane-permeable) strips. These results demonstrate that SNP stimulates guanylate cyclase to produce cGMP and that the relaxant effect of cGMP was predominant on pharmaco-mechanical coupling. The cyclic-GMP system may help in maintaining pregnancy and preventing uterine contractions during exposure to stimulating agonists.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641971     DOI: 10.1016/0028-2243(95)02096-b

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy.

Authors:  C H Acevedo; A Ahmed
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

2.  NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP.

Authors:  I L Buxton; R A Kaiser; N A Malmquist; S Tichenor
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

3.  Hemoxygenase and nitric oxide synthase do not maintain human uterine quiescence during pregnancy.

Authors:  A Barber; S C Robson; F Lyall
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

4.  Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.

Authors:  Tracy A Manuck; W Scott Watkins; Barry Moore; M Sean Esplin; Michael W Varner; G Marc Jackson; Mark Yandell; Lynn Jorde
Journal:  Am J Obstet Gynecol       Date:  2014-03-01       Impact factor: 8.661

5.  Epigenetic Regulation of the Nitric Oxide Pathway, 17-α Hydroxyprogesterone Caproate, and Recurrent Preterm Birth.

Authors:  Tracy A Manuck; Lisa Smeester; Elizabeth M Martin; Martha S Tomlinson; Christina Smith; Michael W Varner; Rebecca C Fry
Journal:  Am J Perinatol       Date:  2017-12-14       Impact factor: 1.862

Review 6.  Pharmacogenomics of preterm birth prevention and treatment.

Authors:  T A Manuck
Journal:  BJOG       Date:  2015-11-06       Impact factor: 6.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.